Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics.
Document Type
Article
Publication Date
1-4-2019
Institution/Department
Surgery, Oncology, Maine Medical Center Research Institute
Journal Title
Int J Environ Res Public Health
MeSH Headings
Female, Humans, Inflammatory Breast Neoplasms, Mastectomy, Middle Aged, Receptors, Estrogen, Receptors, Progesterone, Survival Analysis, Treatment Outcome, Triple Negative Breast Neoplasms
Abstract
In this US-based study of the National Cancer Database (NCDB), we examined 8550 patients diagnosed with non-metastatic, invasive inflammatory breast cancer (IBC) who received surgery from 2004⁻2013. Patients were grouped into four biologic subtypes (HR⁺/HER
ISSN
1660-4601
Recommended Citation
Biswas, Tithi; Jindal, Charulata; Fitzgerald, Timothy L; and Efird, Jimmy T, "Pathologic Complete Response (pCR) and Survival of Women with Inflammatory Breast Cancer (IBC): An Analysis Based on Biologic Subtypes and Demographic Characteristics." (2019). Maine Medical Center. 1628.
https://knowledgeconnection.mainehealth.org/mmc/1628
